129 related articles for article (PubMed ID: 7083732)
1. Effect of indoramin and propranolol on cardiovascular response to cold in hypertensive patients.
Velasco M; Urbina-Quintana A; Andrews-Figueroa P; Nieves D; Hernández E; Guevara-Casado J; Hernández-Pieretti O
Clin Pharmacol Ther; 1982 Jul; 32(1):7-11. PubMed ID: 7083732
[TBL] [Abstract][Full Text] [Related]
2. A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension.
Antani J; Buckle JW; Turner J; Cohen M
Curr Med Res Opin; 1983; 8(9):603-11. PubMed ID: 6365463
[TBL] [Abstract][Full Text] [Related]
3. Propranolol and renal hemodynamics at rest and during exercise.
Malini PL; Strocchi E; Ambrosioni E
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):611-4. PubMed ID: 6668099
[TBL] [Abstract][Full Text] [Related]
4. Double-blind study comparing indoramin and propranolol in the treatment of black patients with hypertension.
Bennett JM; Weich DJ; Schoeman HS
S Afr Med J; 1988 Dec; 74(12):619-21. PubMed ID: 3061032
[TBL] [Abstract][Full Text] [Related]
5. Preliminary observations of chronic indoramin therapy in congestive heart failure.
Leier CV; Huss P; Parrish D; Binkley PF; Unverferth DV
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S112-6. PubMed ID: 2423783
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of intravenous indoramin hydrochloride in man.
Coleman AJ; Leary WP; Asmal AC
J Int Med Res; 1979; 7(6):511-8. PubMed ID: 520654
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic responses to indoramin at rest and during exercise in congestive heart failure.
Leier CV; Majetich N; Binkley PF; Uverferth DV
Pharmacotherapy; 1987; 7(3):61-8. PubMed ID: 3628063
[TBL] [Abstract][Full Text] [Related]
8. Investigation into mechanism of lack of reflex tachycardia in response to hypotensive action of indoramin in dogs.
Harron DW; Kerr MJ; Shanks RG
J Cardiovasc Pharmacol; 1984; 6(4):596-600. PubMed ID: 6206312
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of intravenous indoramin on the hemodynamic adaptation at rest and during exercise in chronic congestive heart failure.
De Kock MR; Detry JM
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S107-11. PubMed ID: 2423782
[TBL] [Abstract][Full Text] [Related]
10. Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.
Holmes B; Sorkin EM
Drugs; 1986 Jun; 31(6):467-99. PubMed ID: 3525084
[TBL] [Abstract][Full Text] [Related]
11. The clinical pharmacology of indoramin.
Shanks RG
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S8-15. PubMed ID: 2423804
[No Abstract] [Full Text] [Related]
12. Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol.
Franciosa JA; Johnson SM; Tobian LJ
Chest; 1980 Aug; 78(2):291-9. PubMed ID: 6995041
[No Abstract] [Full Text] [Related]
13. The effect of indoramin on exercise performance in mild hypertension.
Bishop N; Mackintosh AF; Stoker JB; Mary DA; Linden RJ
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S30-6. PubMed ID: 2423794
[TBL] [Abstract][Full Text] [Related]
14. Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness.
de White C; Royds RB; Turner P
Postgrad Med J; 1974 Dec; 50(590):729-33. PubMed ID: 4469040
[TBL] [Abstract][Full Text] [Related]
15. Effect of indoramin on finger blood flow in vasospastic patients.
Clement DL
Eur J Clin Pharmacol; 1978 Dec; 14(5):331-3. PubMed ID: 729626
[TBL] [Abstract][Full Text] [Related]
16. Alpha-adrenoreceptor blockade with indoramin in hypertension.
Gould BA; Mann S; Davies AB; Altman DG; Raftery EB
J Cardiovasc Pharmacol; 1983; 5(3):343-8. PubMed ID: 6191130
[TBL] [Abstract][Full Text] [Related]
17. Coronary blood flow during exercise following nonselective and selective alpha 1-adrenergic blockade with indoramin.
Dai XZ; Herzog CA; Schwartz JS; Bache RJ
J Cardiovasc Pharmacol; 1986; 8(3):574-81. PubMed ID: 2425176
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the cardiovascular actions of indoramin, propranolol, lignocaine, and quinidine.
Alps BJ; Borrows ET; Johnson ES; Staniforth MW; Wilson AB
Cardiovasc Res; 1972 May; 6(3):226-34. PubMed ID: 4338471
[No Abstract] [Full Text] [Related]
19. Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
Marshall AJ; Kettle MA; Barritt DW
Br J Clin Pharmacol; 1980 Sep; 10(3):217-21. PubMed ID: 7437237
[TBL] [Abstract][Full Text] [Related]
20. Indoramin in heart failure: possible adverse effects on hemodynamics and exercise capacity.
Seth L; Galiè N; Casebolt P; Gimenez H; Malloy M; Franciosa JA
Clin Pharmacol Ther; 1986 Nov; 40(5):567-74. PubMed ID: 3769387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
